Scaly Lentinus

Metadata

Regulatory Status

West Africa (Nigeria, Ghana)

• Traditional medicine: Widely used in Yoruba, Igbo, and other traditional medicine systems for treating coughs, colds, fever, infections, wounds, stomach ailments, and general debility. Often prepared as a soup or decoction. In Yoruba medicine, it is known as “Ero” and used in multi-component herbal formulations. Among the Igbo, it is called “Osu” and valued for both food and medicine.
• Food status: One of the most commonly collected and consumed wild mushrooms in Nigeria and Ghana. Sold in local markets as both fresh and dried product. Increasingly cultivated on agricultural waste substrates (sawdust, rice straw, corn cobs, cassava peel) as part of food security and income-generation programs.
• National pharmacopoeia: Not listed in national pharmacopoeias of West African countries, though it is recognized in ethnobotanical and ethnomycological surveys as a medicinal species. Multiple Nigerian and Ghanaian universities have active research programs investigating its pharmacological properties.
• Cameroon and Central Africa: Also widely collected and consumed in Cameroon, Democratic Republic of Congo, and other Central African countries. Known by various local names across different ethnic groups.

Southeast Asia (Thailand, Malaysia)

• Traditional medicine: Used in Thai and Malaysian folk medicine for treating fever, infections, and digestive complaints. Known as “Hed khon” in Thai. Also used among indigenous Orang Asli communities in Malaysia as a general tonic and for treating infections.
• Food status: Consumed as a food mushroom in rural communities. Available in local markets in some regions. Increasingly cultivated on rubber wood sawdust and other agricultural wastes in Thailand and Malaysia.
• Philippines and Indonesia: Collected and consumed as a wild food. Known by various local names. Research on cultivation methods using locally available substrates is ongoing at several Southeast Asian universities.

United States

• Not marketed as a dietary supplement or food product. Not known in the US market. The species does not occur naturally in North America and is not commercially cultivated there.
• No FDA recognition or GRAS determination.
• Research interest: Some US-based researchers have studied L. squarrosulus in the context of tropical ethnomycology and bioprospecting, but no US-based clinical or product development programs exist.

European Union

• No novel food authorization. Not commercially available in the EU market.
• No regulatory assessment has been conducted.

China

• Limited use: While L. squarrosulus occurs in southern China (Yunnan, Guangxi, Hainan), it is not a major species in traditional Chinese medicine. Some overlap with the broader Lentinus genus used in folk medicine practices. Not listed in the Chinese Pharmacopoeia.
• Research: Some Chinese research groups have studied the polysaccharide composition and antimicrobial properties of L. squarrosulus, contributing to the overall evidence base.

India

• Food and folk medicine: Consumed as a food mushroom and folk remedy in parts of southern and northeastern India (Kerala, Karnataka, Assam, Meghalaya). Used traditionally for respiratory complaints and as a general tonic.
• Cultivation research: Indian agricultural universities, particularly in tropical regions, are actively developing cultivation protocols for L. squarrosulus using locally available substrates (coconut coir, banana pseudo-stem, paddy straw).

Conditions & Indications

Primary: Immune Modulation (Preclinical Evidence)

• Polysaccharide immunostimulation: Beta-glucan and heteropolysaccharide fractions from L. squarrosulus stimulate innate immune cell activation, enhancing macrophage phagocytosis, nitric oxide production, and pro-inflammatory cytokine secretion (TNF-alpha, IL-1beta, IL-6). Water-soluble polysaccharide fractions have demonstrated dose-dependent immune activation in cell culture and animal models.
• Splenocyte proliferation: Polysaccharide extracts stimulate the proliferation of murine splenocytes, indicating broad immune activation affecting both innate and adaptive immune compartments.
• NK cell enhancement: Preliminary evidence suggests enhanced natural killer cell cytotoxicity following polysaccharide treatment in animal models.

Secondary: Antimicrobial Activity (Preclinical Evidence)

• Broad-spectrum antibacterial: Ethanol, methanol, and aqueous extracts demonstrate significant antibacterial activity against both gram-positive (Staphylococcus aureus, Bacillus subtilis, Streptococcus pyogenes) and gram-negative (Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonella typhi) bacteria. The antimicrobial activity of L. squarrosulus is consistently reported across multiple research groups in Nigeria, Ghana, and Thailand.
• Anti-MRSA activity: Extracts show activity against methicillin-resistant Staphylococcus aureus (MRSA), a clinically significant finding given the global challenge of antibiotic resistance.
• Antifungal activity: Activity demonstrated against Candida albicans, Aspergillus niger, and Aspergillus flavus in vitro.
• Traditional validation: The traditional use of L. squarrosulus for treating infections aligns with the demonstrated broad-spectrum antimicrobial properties, providing ethnopharmacological plausibility.

Secondary: Antioxidant and Anti-inflammatory Activity (Preclinical Evidence)

• Antioxidant capacity: Extracts demonstrate strong DPPH radical scavenging, ABTS radical decolorization, ferric reducing power, superoxide anion scavenging, and metal chelation activity. Phenolic compounds (gallic acid, tannic acid) and flavonoids (quercetin, rutin) are the primary contributors. The total phenolic content of ethanol extracts is typically in the range of 15-40 mg gallic acid equivalents per gram of dry extract, which is comparable to or higher than many other edible mushroom species.
• Anti-inflammatory effects: Extracts inhibit production of pro-inflammatory mediators (NO, TNF-alpha, IL-6, IL-1beta, PGE2) in LPS-stimulated macrophage models (RAW264.7). The anti-inflammatory mechanism involves suppression of NF-kB signaling pathway, inhibition of IkB phosphorylation, and reduced COX-2 and iNOS expression at both protein and mRNA levels.
• In vivo anti-inflammatory: Animal studies using carrageenan-induced paw edema and cotton pellet granuloma models demonstrate significant anti-inflammatory activity comparable to reference NSAIDs (indomethacin, diclofenac) at tested doses. The anti-inflammatory effect shows dose-dependent behavior, with maximal inhibition typically observed at the highest tested doses (400-500 mg/kg body weight in rats).

Emerging/Preclinical

• Anticancer potential: Crude extracts and polysaccharide fractions demonstrate cytotoxic effects against various cancer cell lines (breast MCF-7, cervical HeLa, liver HepG2, colon HT-29) in vitro. Mechanisms include cell cycle arrest at G0/G1 and G2/M phases, apoptosis induction through caspase activation, and inhibition of cell migration. Some studies report selective cytotoxicity (higher activity against cancer cells compared to normal cells such as Vero cells), suggesting a therapeutic window that warrants further investigation.
• Antidiabetic activity: Extracts demonstrate alpha-glucosidase and alpha-amylase inhibitory activity in vitro, with IC50 values that approach those of the reference drug acarbose in some preparations. Animal studies in alloxan-induced diabetic rats show dose-dependent improvements in fasting blood glucose, lipid profiles (reduced TC, TG, LDL; increased HDL), and liver/kidney function markers (ALT, AST, ALP, creatinine, urea).
• Hepatoprotective effects: Aqueous extracts provide protection against carbon tetrachloride-induced and paracetamol-induced hepatotoxicity in animal models, reducing elevated liver enzymes (ALT, AST, ALP) and improving histological markers. The hepatoprotective mechanism involves enhanced endogenous antioxidant enzyme activities (SOD, catalase, glutathione peroxidase) and reduced malondialdehyde (MDA) levels, indicating attenuation of lipid peroxidation.
• Wound healing: Topical application of L. squarrosulus extracts accelerates wound closure in excision wound models in rats, consistent with the traditional use for wound treatment. The wound-healing effect is likely mediated by the combined antimicrobial, anti-inflammatory, collagen-promoting, and angiogenesis-supporting activities. Enhanced epithelialization and granulation tissue formation have been observed histologically.
• Anthelmintic activity: Extracts demonstrate in vitro activity against intestinal helminths, including dose-dependent paralysis and death of adult earthworms (Pheretima posthuma) used as model organisms. This supports the traditional use for parasitic infections in rural communities.
• Larvicidal potential: Some studies report larvicidal activity against mosquito larvae, suggesting potential applications in vector-borne disease control in tropical regions where the mushroom is readily available.

Mechanism of Action

Primary Mechanisms

1. Polysaccharide-mediated immune activation: Beta-glucans and heteropolysaccharides from L. squarrosulus activate innate immune cells through binding to pattern recognition receptors — primarily dectin-1 (for beta-1,3-glucans), complement receptor 3 (CR3), and Toll-like receptor 2 (TLR-2). This receptor engagement triggers intracellular signaling cascades (NF-kB, MAPK/ERK, PI3K/Akt) that result in: (a) enhanced macrophage phagocytosis and respiratory burst activity; (b) increased production of pro-inflammatory and immunoregulatory cytokines (TNF-alpha, IL-1beta, IL-6, IL-12, IFN-gamma); (c) upregulation of co-stimulatory molecules on antigen-presenting cells, enhancing adaptive immune responses; (d) stimulation of NK cell cytotoxic activity. The immunostimulatory mechanism parallels that of well-studied medicinal mushroom polysaccharides (lentinan from shiitake, schizophyllan from Schizophyllum, PSK from turkey tail).

2. Phenolic and flavonoid antioxidant defense: Gallic acid, tannic acid, quercetin, rutin, and related compounds exert antioxidant effects through multiple mechanisms: (a) direct free radical scavenging via hydrogen atom or electron donation from hydroxyl groups; (b) chelation of pro-oxidant transition metal ions (Fe2+, Cu2+), preventing Fenton reaction-mediated hydroxyl radical generation; (c) upregulation of endogenous antioxidant enzyme systems (SOD, catalase, glutathione peroxidase, glutathione reductase) through Nrf2 pathway activation; (d) inhibition of pro-oxidant enzymes (xanthine oxidase, NADPH oxidase). The combined phenolic-flavonoid content provides multi-layered antioxidant protection.

3. NF-kB-mediated anti-inflammatory activity: Anti-inflammatory compounds in L. squarrosulus suppress the NF-kB inflammatory signaling pathway by inhibiting IkB kinase (IKK)-mediated phosphorylation and degradation of IkBa, thereby preventing nuclear translocation of NF-kB p65/p50 heterodimers. This blocks transcription of pro-inflammatory genes encoding iNOS (nitric oxide synthase), COX-2 (cyclooxygenase-2), TNF-alpha, IL-1beta, and IL-6. The dual immunostimulatory (polysaccharide) and anti-inflammatory (phenolic/flavonoid) activities are not contradictory — they represent immunomodulation toward balanced immune function rather than simple immunostimulation.

Secondary Mechanisms

• Antimicrobial mechanisms: The broad-spectrum antimicrobial activity likely involves: (a) phenolic compound-mediated disruption of bacterial cell membranes, altering permeability and causing leakage of intracellular contents; (b) inhibition of bacterial enzymes by flavonoid-metal complexes; (c) terpenoid-mediated membrane destabilization; (d) oxalic acid contribution to acidic pH effects on microbial viability.
• Alpha-glucosidase inhibition: Phenolic compounds and flavonoids (particularly quercetin) competitively inhibit intestinal alpha-glucosidase, slowing the hydrolysis of complex carbohydrates to glucose and reducing postprandial blood glucose elevation.
• Lectin-mediated bioactivity: Lectins from L. squarrosulus bind cell surface glycan structures, potentially modulating cell signaling, immune cell activation, and cell-cell interactions. Lectin characterization for this species is incomplete.

Clinical Evidence Summary

No human clinical trials, case reports, or observational studies have been published for Lentinus squarrosulus. All pharmacological evidence derives from in vitro cell culture and animal model studies, though the body of preclinical research is substantial and comes from multiple independent research groups.

Key Preclinical Studies

Ethnomycological Evidence

Evidence Limitations

• No human clinical trials. Despite extensive traditional use across West Africa and Southeast Asia, no controlled clinical studies have been published.
• Predominantly in vitro studies: Most pharmacological data come from cell culture and enzyme inhibition assays. Animal studies exist but are limited in number and methodological rigor.
• Lack of standardization: Studies use crude extracts with variable preparation methods, making cross-study comparison difficult. No standardized extract with defined bioactive content has been developed.
• Taxonomic considerations: L. squarrosulus is morphologically variable, and some older studies may have confused it with L. tigrinus or other Lentinus species. Molecular identification was not always performed.
• Dose-response gaps: Many studies report single-dose or narrow dose-range effects without systematic dose-response characterization.
• Bioavailability unknown: The oral bioavailability of the key bioactive compounds (polysaccharides, phenolics, flavonoids) from crude mushroom preparations has not been characterized.
• Western research neglect: Despite its widespread use and cultural significance in tropical regions, L. squarrosulus has received comparatively little attention from well-funded Western research institutions, resulting in lower methodological rigor in some published studies.

Safety Profile

General Assessment

Lentinus squarrosulus has a long history of safe food consumption in West Africa and Southeast Asia, where it is one of the most commonly collected and consumed wild mushrooms. At food-level consumption, it is considered safe for the general population in these regions. No significant toxicity reports have been documented in the ethnomycological literature.

Contraindications

• Mushroom allergy: Individuals with known allergy to Lentinus species or other basidiomycete mushrooms should avoid consumption.
• Pregnancy and lactation: Insufficient safety data for medicinal-dose supplementation. Traditional food consumption during pregnancy has not been specifically studied but is practiced without reported adverse outcomes in West African communities.

Drug Interactions

• No documented drug interactions. Theoretical interactions based on preclinical data:
  • Antidiabetic medications: The alpha-glucosidase inhibitory and glucose-lowering effects observed in animal models suggest theoretical additive hypoglycemic effects when combined with insulin or oral hypoglycemics.
  • Immunosuppressants: The immunostimulatory polysaccharides could theoretically counteract immunosuppressive therapy. This interaction is speculative and based on class effects of mushroom beta-glucans.
  • Antibiotics: Theoretical additive antimicrobial effects, unlikely to be clinically significant.

Side Effects (at Food-Level Consumption)

• Common: No significant adverse effects at normal dietary intake levels as practiced traditionally in West Africa and Southeast Asia. L. squarrosulus has been consumed for generations without reported adverse effects.
• Uncommon: Mild gastrointestinal discomfort from the fibrous texture, particularly if consumed in large quantities or by individuals not accustomed to high-fiber mushroom consumption. The tough, chewy texture can cause mechanical irritation of the GI tract if inadequately cooked.
• Rare: Allergic reactions in sensitized individuals (not specifically documented for L. squarrosulus but possible based on class effects of basidiomycete proteins and spores).
• Preparation note: Thorough cooking is essential to improve digestibility. Traditional preparations (simmering in soups and stews) achieve adequate cooking. Raw or undercooked consumption is not practiced traditionally and is not recommended.

Toxicology

• General: Not considered toxic based on long history of food use across multiple continents and cultures. No acute or subchronic toxicity studies have been published for standardized extracts, reflecting the general acceptance of this species as a safe food mushroom.
• Heavy metals: Wild-harvested specimens may accumulate heavy metals depending on soil and substrate conditions. This is a general concern for wild-harvested mushrooms in tropical regions, particularly near mining areas, industrial zones, or areas with contaminated groundwater.
• Oxalic acid content: L. squarrosulus contains oxalic acid, which in high concentrations could contribute to kidney stone formation in susceptible individuals with a history of calcium oxalate nephrolithiasis. The oxalic acid content from food-level consumption is unlikely to be clinically significant for the general population.
• Substrate contamination: When cultivated on agricultural waste substrates, the quality of substrate materials (potential pesticide residues, fungicide contamination, aflatoxin contamination in grain-based substrates) should be verified. Substrates sourced from conventional agriculture may contain residual agrochemicals.
• Identification safety: In regions where L. squarrosulus is wild-harvested, foragers should be confident in their identification skills. While L. squarrosulus itself is not toxic, confusion with other white-spored mushrooms growing on wood could potentially lead to misidentification. Expert guidance or molecular confirmation is recommended when collecting unfamiliar specimens.
• Microbial contamination: In tropical climates, rapid post-harvest microbial colonization (bacterial and mold contamination) can occur if mushrooms are not properly handled, stored, or dried promptly after harvest. Proper post-harvest handling is essential for food safety.

Clinical Dosage

Traditional Use (Culinary and Medicinal)

• Food consumption: Consumed fresh or dried as a food mushroom across West Africa and Southeast Asia. Typical preparation involves simmering in soups, stews, or broths. No standardized dose; quantities vary by cultural practice and availability. In Nigeria, L. squarrosulus is commonly prepared in “mushroom pepper soup” — a traditional recipe with onions, chili peppers, and various local spices.
• Decoction: In Nigerian and Ghanaian folk medicine, dried fruiting bodies are boiled in water to prepare a medicinal decoction consumed for fever, coughs, infections, and stomach complaints. Traditional doses are not standardized but typically involve boiling 20-50 g of dried mushroom in 500-1000 mL of water until the volume is reduced by half.
• Topical: In some traditions, crushed or powdered fruiting body material is applied directly to wounds for healing. The antimicrobial properties provide a rational basis for this application.
• Dried preservation: In West African markets, L. squarrosulus is commonly sold in dried form, extending shelf life in tropical conditions where refrigeration may not be available. Sun-drying is the traditional method; oven-drying is increasingly used for commercial production.

Research Preparations (No Established Human Dosage)

• Aqueous extracts: Studied at 100-500 mg/kg body weight in animal models for antidiabetic and hepatoprotective effects. Aqueous extraction captures water-soluble polysaccharides, proteins, and hydrophilic phenolics.
• Ethanol extracts: Studied at variable concentrations for antimicrobial and antioxidant activity in vitro. Ethanol extraction captures phenolic compounds, flavonoids, terpenoids, and other lipophilic bioactives.
• Methanol extracts: Used in phytochemical screening studies. Not suitable for human consumption due to solvent residues.
• Polysaccharide fractions: Immunomodulatory polysaccharides studied at 50-200 mg/kg in animal models. Hot-water extraction followed by ethanol precipitation is the standard method for polysaccharide isolation.
• No commercially standardized medicinal extract products are available internationally. All research uses custom-prepared extracts with variable standardization.

Morphological Description

• Cap: 3-12 cm across, convex to flat, white to pale buff, covered with distinctive scaly or squarrose (upturned scale-like) projections that give the species its name
• Gills: White to cream, decurrent (running down the stipe), closely spaced
• Stipe: Central, 3-8 cm long, white, firm, often with scales matching the cap
• Flesh: White, tough, fibrous; requires thorough cooking for palatability
• Spore print: White
• Habitat: On dead or dying hardwood logs, stumps, and branches in tropical and subtropical forests; common on mango, rubber, neem, and various tropical hardwoods

Cultivation and Substrate Considerations

• Substrate options: L. squarrosulus is cultivated on a variety of lignocellulosic agricultural wastes in tropical regions, including sawdust, rice straw, corn cobs, sugarcane bagasse, palm kernel shell, and cassava peel. The choice of substrate affects both yield and bioactive content.
• Temperature range: Optimum fruiting temperature is 25-32 C, making it well-suited to tropical cultivation without environmental control infrastructure.
• Biological efficiency: Biological efficiency (fresh mushroom weight / dry substrate weight x 100) ranges from 30-70% depending on substrate and cultivation conditions, which is lower than Pleurotus species but adequate for small-scale tropical cultivation.
• Spawn production: Grain-based spawn (sorghum, millet, or rice grain) is used for inoculation. Spawn run typically requires 14-21 days at 25-30 C.

Form Selection Guidance

L. squarrosulus is primarily consumed as a traditional food and folk remedy in tropical regions. No standardized medicinal extract products are available on the international market. For individuals in regions where this mushroom is traditionally consumed, food-level consumption as part of regular diet provides the broadest spectrum of bioactives in a traditional food matrix. For targeted immunomodulatory, antimicrobial, or antioxidant applications, better-studied species with clinical evidence — particularly Shiitake (Lentinula edodes, a closely related genus with clinical-grade lentinan), Turkey Tail (Trametes versicolor, with clinically validated PSK/PSP), or Schizophyllum commune (with clinically validated schizophyllan) — are recommended.

Nutritional Profile

Macronutrient Composition (per 100 g dry weight, approximate)

Micronutrient Highlights

• Minerals: Rich in potassium (K) and phosphorus (P). Contains significant iron (Fe), calcium (Ca), zinc (Zn), and magnesium (Mg). Mineral content varies considerably with substrate composition.
• Essential amino acids: Contains all essential amino acids, with leucine, lysine, and valine as the most abundant. The protein quality is comparable to other edible mushrooms and significantly exceeds most plant foods, making L. squarrosulus an important protein source in food-insecure tropical communities.
• Vitamins: Contains B-complex vitamins including thiamine (B1), riboflavin (B2), and niacin (B3). Vitamin C has been detected in some analyses.
• Fatty acid profile: Linoleic acid (C18:2) is the dominant fatty acid, followed by oleic acid (C18:1) and palmitic acid (C16:0). The polyunsaturated-to-saturated fatty acid ratio is favorable.

Food Security Significance

In West Africa, L. squarrosulus is recognized by the FAO as an important wild food resource contributing to food security and nutrition in rural communities. Its high protein content, complete amino acid profile, and cultivation potential on agricultural waste substrates make it a valuable tool for addressing protein malnutrition in tropical regions. Women in particular are involved in wild mushroom collection and trade, making L. squarrosulus an important species for gender-inclusive food security and income generation strategies.

Sources

• Okwulehie IC, Ogoke JA. Bioactive, nutritional and heavy metal constituents of some edible mushrooms found in Abia State of Nigeria. Int J Appl Microbiol Biotechnol Res. 2013;1:7-15
• Aina DA, Jonathan SG, Olawuyi OJ, Ojelabi DO, Durowoju BM. Antioxidant, antimicrobial and phytochemical properties of alcoholic extracts of Lentinus squarrosulus — a Nigerian medicinal macrofungus. Afr J Tradit Complement Altern Med. 2012;9(4):560-564
• Sudirman LI, Herpandi, Lefebvre G, et al. Immunomodulatory activity of the water-soluble polysaccharides from Lentinus squarrosulus and Schizophyllum commune. HAYATI J Biosci. 2015;22(2):76-81
• Boonloh K, Kukongviriyapan V, Kongyingyoes B, et al. Rice bran protein hydrolysates improve insulin resistance and decrease pro-inflammatory cytokine gene expression in rats fed a high carbohydrate-high fat diet. Nutrients. 2015;7(8):6313-6329
• Jonathan SG, Fasidi IO. Studies on Psathyrella atroumbonata (Pegler), a Nigerian edible fungus. Food Chem. 2003;81(4):481-484
• Nwachukwu E, Uzoeto HO. Antimicrobial activity of some local mushrooms on pathogenic isolates. J Med Plants Res. 2010;4(23):2460-2465
• Afieroho OE, Lawson L, Adedokun OM, Emenyonu N. Antimicrobial and cytotoxic activities of Lentinus squarrosulus from Southeast Nigeria. J Pharm Res. 2013;7(4):297-301
• Gbolagade J, Ajayi A, Oku I, Wankasi D. Nutritive value of common wild edible mushrooms from southern Nigeria. Global J Biotechnol Biochem. 2006;1(1):16-21
• Oyetayo VO. Medicinal uses of mushrooms in Nigeria: towards full and sustainable exploitation. Afr J Tradit Complement Altern Med. 2011;8(3):267-274
• Thetsrimuang C, Khammuang S, Chiablaem K, Srisomsap C, Sarnthima R. Antioxidant properties and cytotoxicity of crude polysaccharides from Lentinus polychrous Lev. Food Chem. 2011;128(3):634-639
• Tijani AA, Akinrinde AS, Adeniyi TD. Polysaccharide-rich extract of Lentinus squarrosulus attenuates hyperglycemia and oxidative stress in alloxan-induced diabetic rats. J Complement Integr Med. 2018;15(3):20170175
• Stamets P. Mycelium Running: How Mushrooms Can Help Save the World. Berkeley, CA: Ten Speed Press; 2005
• Boa E. Wild Edible Fungi: A Global Overview of Their Use and Importance to People. FAO Non-Wood Forest Products Series No. 17. Rome: Food and Agriculture Organization of the United Nations; 2004

Connections

• Lentinus-Lentinula relationship: L. squarrosulus belongs to the genus Lentinus, which is phylogenetically related to but distinct from Lentinula, the genus containing Shiitake (Lentinula edodes). Both genera produce wood-decaying mushrooms with polysaccharide-driven immunomodulatory properties, but shiitake has undergone far more extensive clinical development (lentinan is an approved pharmaceutical in Japan), making it the clinically validated reference point for the Lentinus/Lentinula clade. Despite the similar genus names, Lentinus and Lentinula are now placed in different families based on molecular phylogenetics.
• Tropical immunomodulatory mushrooms: L. squarrosulus shares the tropical distribution and traditional medicinal use pattern with Schizophyllum commune, another pan-tropical species with polysaccharide immunomodulatory activity. Both are widely used in tropical folk medicine and are increasingly cultivated on agricultural waste. Schizophyllan from S. commune has advanced to clinical trials in Japan for cancer adjunctive therapy, representing the level of clinical development that L. squarrosulus polysaccharides might aspire to with adequate research investment.
• West African ethnomycology: Within the West African ethnomycological tradition, L. squarrosulus is one of the most important medicinal and edible mushrooms alongside Pleurotus species and Termitomyces titanicus. The depth of traditional knowledge in Yoruba and Igbo medicine represents an underutilized resource for bioprospecting and drug discovery. The FAO has recognized L. squarrosulus as an important wild food resource for food security in tropical Africa.
• Polysaccharide immunomodulators: The beta-glucan-driven immunostimulatory mechanism of L. squarrosulus belongs to the same pharmacological class as lentinan (shiitake), PSK/PSP (Turkey Tail), schizophyllan (S. commune), and pleuran (Oyster Mushroom). The consistent demonstration of this mechanism across diverse mushroom taxa strengthens the biological plausibility of immunomodulatory claims for less-studied species like L. squarrosulus.
• Research equity gap: L. squarrosulus exemplifies the disparity between the depth of traditional knowledge (extensive across West Africa and Southeast Asia) and the level of modern clinical investigation (minimal). This gap reflects broader patterns of research funding allocation that favor species already established in Western and East Asian markets. The growing capacity of African and Southeast Asian research institutions for pharmacological investigation offers hope that this gap will narrow in coming years.
• Agricultural waste valorization: L. squarrosulus cultivation transforms low-value agricultural residues (sawdust, rice straw, corn cobs, sugarcane bagasse) into a high-value protein source. After fruiting, the spent substrate serves as nutrient-rich compost or animal feed supplement. This circular bioeconomy model connects L. squarrosulus to broader sustainability goals in tropical agriculture.